Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $6.65 and traded as low as $5.85. Predictive Oncology shares last traded at $6.05, with a volume of 527,226 shares traded.
Predictive Oncology Stock Performance
The company has a 50-day simple moving average of $10.18 and a 200-day simple moving average of $6.65. The stock has a market cap of $20.53 million, a P/E ratio of -0.45 and a beta of 1.35.
Predictive Oncology Company Profile
Predictive Oncology Inc (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence, machine learning, and laboratory-based cancer research to drug discovery and precision oncology. The company uses tumor samples and related biological data to study how individual cancers may respond to potential treatments.
Its technology offerings have included AI-enabled platforms designed to analyze cancer data, identify potential drug candidates, and predict treatment responses.
Recommended Stories
- Five stocks we like better than Predictive Oncology
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
